Cell Culture Market by Consumables [Media, Sera, Reagents (Supplements, Buffers)], Vessels (Plates, Flask, Roller Bottle), Equipment (Bioreactor, Filtration, Incubators, Centrifuge), Application (mAbs, Vaccines, CGT), Competition - Global Forecast to 2031
The cell culture market is projected to reach USD 58.42 billion by 2031 from an estimated USD 33.07 billion in 2026, at a CAGR of 12.1% during the forecast period of 2026 to 2031. The growth of this market can be attributed to increasing investment and funding for research in cell biology. The rising incidence of chronic diseases such as cancer is boosting the demand for advanced therapies such as tissue engineering and regenerative medicine. This trend is expected to drive the growth of the cell culture market in the coming years.
By application, the biopharmaceutical production segment accounted for the largest share of the market in 2025.
In 2025, the biopharmaceutical production segment accounted for the largest share of the application segment in the global cell culture market. The biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, thereby promoting the growth of biopharmaceutical production in the cell culture market.
The sera, media, and reagents segment accounted for a major share of the consumables market in 2025.
The cell culture consumables market is categorized by type into sera, media, and reagents; vessels; and accessories. The sera, media, and reagents segment accounted for the largest share of the cell culture consumables market in 2025. The large share of this segment is attributed to repeated bulk purchases and the need for consumables in the biotechnology and pharmaceutical industries. Research labs and production facilities often require large quantities of sera, media, reagents, vessels, and accessories to sustain continuous cell culture activities. This leads to frequent and substantial procurement for experimentation, testing, and manufacturing processes.
The Asia Pacific region is expected to experience the highest CAGR in the cell culture market from 2026 to 2031.
The cell culture market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biologics and biosimilar manufacturing, rising vaccine production, increasing cell & gene therapy activity, and growing government support for domestic biomanufacturing. Countries such as China, India, Japan, South Korea, and Australia are strengthening their cell culture capabilities through investments in biopharmaceutical production, regenerative medicine, stem cell research, and advanced bioprocessing infrastructure. The region is also benefiting from growing CDMO activity, cost-efficient manufacturing, rising clinical research, and wider adoption of serum-free media, single-use systems, culture vessels, reagents, and other cell culture consumables.
The primary interviews conducted for this report can be categorized as follows:
Research Coverage
This research report categorizes the cell culture market by product [consumables (sera, media, reagents; vessels, and other consumables & accessories), equipment (supporting equipment, bioreactors, and storage equipment)], application [biopharmaceutical production (monoclonal antibody production, vaccine production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications], end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the cell culture market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the cell culture market.
Key Benefits of Buying the Report
This report offers a comprehensive overview of the cell culture market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies
The report provides insights on the following pointers:
By application, the biopharmaceutical production segment accounted for the largest share of the market in 2025.
In 2025, the biopharmaceutical production segment accounted for the largest share of the application segment in the global cell culture market. The biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, thereby promoting the growth of biopharmaceutical production in the cell culture market.
The sera, media, and reagents segment accounted for a major share of the consumables market in 2025.
The cell culture consumables market is categorized by type into sera, media, and reagents; vessels; and accessories. The sera, media, and reagents segment accounted for the largest share of the cell culture consumables market in 2025. The large share of this segment is attributed to repeated bulk purchases and the need for consumables in the biotechnology and pharmaceutical industries. Research labs and production facilities often require large quantities of sera, media, reagents, vessels, and accessories to sustain continuous cell culture activities. This leads to frequent and substantial procurement for experimentation, testing, and manufacturing processes.
The Asia Pacific region is expected to experience the highest CAGR in the cell culture market from 2026 to 2031.
The cell culture market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biologics and biosimilar manufacturing, rising vaccine production, increasing cell & gene therapy activity, and growing government support for domestic biomanufacturing. Countries such as China, India, Japan, South Korea, and Australia are strengthening their cell culture capabilities through investments in biopharmaceutical production, regenerative medicine, stem cell research, and advanced bioprocessing infrastructure. The region is also benefiting from growing CDMO activity, cost-efficient manufacturing, rising clinical research, and wider adoption of serum-free media, single-use systems, culture vessels, reagents, and other cell culture consumables.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side (70%) and Demand Side (30%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)
Research Coverage
This research report categorizes the cell culture market by product [consumables (sera, media, reagents; vessels, and other consumables & accessories), equipment (supporting equipment, bioreactors, and storage equipment)], application [biopharmaceutical production (monoclonal antibody production, vaccine production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications], end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the cell culture market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the cell culture market.
Key Benefits of Buying the Report
This report offers a comprehensive overview of the cell culture market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies
The report provides insights on the following pointers:
- Analysis of key drivers (increasing support and funding for cell-based research, rising demand for serum-free and animal component-free media, growing popularity of monoclonal antibodies and biosimilars, increasing adoption of single-use technologies, and growth in advanced therapy medicinal products), restraints (high cost of cell biology research and limitations in producing high-density cell cultures), opportunities (growing opportunities in emerging economies, rising demand for 3D cell culture, and Increasing focus on next-generation therapeutics), and challenges (ethical concern regarding cell usage, and disposal of plastic consumables) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the cell culture market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell culture market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf K?hner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.3.4 UNIT CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN CELL CULTURE MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 CELL CULTURE MARKET OVERVIEW
3.2 NORTH AMERICA: CELL CULTURE MARKET, BY CONSUMABLE AND COUNTRY
3.3 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 CELL CULTURE MARKET SHARE, BY END USER
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing support and funding for cell-based research
4.2.1.2 Rising demand for serum-free and animal component-free media
4.2.1.3 Growing popularity of monoclonal antibodies and biosimilars
4.2.1.4 Increasing adoption of single-use technologies
4.2.1.5 Growth in advanced therapy medicinal products
4.2.2 RESTRAINTS
4.2.2.1 High cost of cell biology research
4.2.2.2 Limitations in producing high-density cell cultures
4.2.3 OPPORTUNITIES
4.2.3.1 Rising demand for 3D cell culture
4.2.3.2 Growth opportunities in emerging economies
4.2.3.3 Increasing focus on next-generation therapeutics
4.2.4 CHALLENGES
4.2.4.1 Disposal of plastic consumables
4.2.4.2 Ethical concerns related to cell usage
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL CELL CULTURE INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.5.2 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION
5.6 TRADE ANALYSIS
5.6.1 IMPORT SCENARIO (HS CODE 382100)
5.6.2 EXPORT SCENARIO (HS CODE 382100)
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10 IMPACT OF 2025 US TARIFFS ON CELL CULTURE MARKET
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END-USE INDUSTRIES
5.10.5.1 Pharmaceutical & biotech companies
5.10.5.2 Hospitals & diagnostic laboratories
5.10.5.3 Academic & research institutes
5.10.5.4 Contract research organizations & contract development and manufacturing organizations
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 Single-use technology
6.1.1.2 Flow cytometry
6.1.1.3 Microscopy
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 High-throughput screening
6.1.2.2 Mass spectrometry
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Microfluidics and organ-on-a-chip
6.1.3.2 3D bioprinting
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR CELL CULTURE PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON CELL CULTURE MARKET
6.5.1 BEST PRACTICES IN CELL CULTURE WORKFLOW
6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 CELL CULTURE MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 SERA, MEDIA, AND REAGENTS
9.2.1.1 Media
9.2.1.1.1 Serum-free media
9.2.1.1.1.1 CHO media
9.2.1.1.1.1.1 High-yield biologics manufacturing to sustain demand for optimized CHO serum-free media
9.2.1.1.1.2 HEK 293 media
9.2.1.1.1.2.1 Viral vector manufacturing and transient expression workflows to accelerate HEK 293 media adoption
9.2.1.1.1.3 Serum-free stem cell media
9.2.1.1.1.3.1 Regenerative medicine, iPSC models, and cell therapy translation to drive specialized stem cell media demand
9.2.1.1.1.4 Vero Cell media
9.2.1.1.1.4.1 Increasing vaccine manufacturing to support demand for serum-free Vero cell media
9.2.1.1.1.5 BHK media
9.2.1.1.1.5.1 Vaccine production and viral vector workflows to support demand for BHK serum-free media
9.2.1.1.1.6 Other serum-free media
9.2.1.1.2 Classical media & salts
9.2.1.1.2.1 Standardized basal media and salt solutions to support routine culture, assay reproducibility, and vaccine production
9.2.1.1.3 Stem cell culture media
9.2.1.1.3.1 Rising use of stem cell models and regenerative medicine workflows to drive demand for specialized culture media
9.2.1.1.4 Chemically-defined media
9.2.1.1.4.1 Increasing need for reproducible, animal component-free workflows to support biologics and advanced therapy development
9.2.1.1.5 Specialty media
9.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost market
9.2.1.1.6 Other media
9.2.1.2 Reagents
9.2.1.2.1 Growth factors
9.2.1.2.1.1 Need to regulate cell proliferation, differentiation, and migration to sustain growth
9.2.1.2.2 Supplements
9.2.1.2.2.1 Need to improve cell growth, nutrient availability, and bioproduction performance to support segment growth
9.2.1.2.3 Buffers & chemicals
9.2.1.2.3.1 Ability to maintain stable pH levels to facilitate growth
9.2.1.2.4 Cell dissociation reagents
9.2.1.2.4.1 Ability to minimize cell stress and reduce cell damage to foster growth
9.2.1.2.5 Balanced salt solutions
9.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to assist growth
9.2.1.2.6 Attachment & matrix factors
9.2.1.2.6.1 Rising adoption of 3D cell culture models to support growth
9.2.1.2.7 Antibiotics/Antimycotics
9.2.1.2.7.1 Ability to mitigate growth of contaminating bacteria, fungi, and mycoplasma to drive market
9.2.1.2.8 Cryoprotective reagents
9.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to aid growth
9.2.1.2.9 Contamination detection kits
9.2.1.2.9.1 Need for rapid identification of microbial contaminants to promote growth
9.2.1.2.10 Other reagents
9.2.1.3 Sera
9.2.1.3.1 Fetal bovine sera
9.2.1.3.1.1 Increasing role of fetal bovine sera in cell proliferation to favor growth
9.2.1.3.2 Adult bovine sera
9.2.1.3.2.1 Cost-effectiveness to contribute to growth
9.2.1.3.3 Other animal sera
9.2.2 VESSELS
9.2.2.1 Cell factory systems/cell stacks
9.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive adoption
9.2.2.2 Roller/roux bottles
9.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth
9.2.2.3 Flasks
9.2.2.3.1 Growing advancements in cell culture flasks to boost market
9.2.2.4 Multiwell plates
9.2.2.4.1 Increasing adoption of multiwell plates in high-throughput or high-content screening to aid growth
9.2.2.5 Petri dishes
9.2.2.5.1 Rising use of petri dishes as sterile containers to sustain growth
9.2.3 OTHER CONSUMABLES & ACCESSORIES
9.2.3.1 Reduced preparation time and equipment performance improvements to augment growth
9.3 EQUIPMENT
9.3.1 SUPPORTING EQUIPMENT
9.3.1.1 Filtration systems
9.3.1.1.1 Sterile filtration for contamination-controlled workflows to boost market
9.3.1.2 Cell counters
9.3.1.2.1 Growing adoption of automated cell counters to propel market
9.3.1.3 Carbon dioxide incubators
9.3.1.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market
9.3.1.4 Centrifuges
9.3.1.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges
9.3.1.5 Autoclaves
9.3.1.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves
9.3.1.6 Microscopes
9.3.1.6.1 Rising adoption of live-cell imaging in 3D culture and stem cell models to support segment growth
9.3.1.7 Biosafety cabinets
9.3.1.7.1 Rising focus on contamination control and operator safety to support segment growth
9.3.1.8 Other supporting equipment
9.3.2 BIOREACTORS
9.3.2.1 Rising biologics and advanced therapy production to accelerate adoption of scalable bioreactor systems
9.3.3 STORAGE EQUIPMENT
9.3.3.1 Refrigerators & freezers
9.3.3.1.1 Increasing need for storage solutions to propel market
9.3.3.2 Cryostorage systems
9.3.3.2.1 Benefits of long-term preservation of cell cultures to support growth
10 CELL CULTURE MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 BIOPHARMACEUTICAL PRODUCTION
10.2.1 MONOCLONAL ANTIBODY PRODUCTION
10.2.1.1 Increasing approval and launch of monoclonal antibodies to amplify growth
10.2.2 VACCINE PRODUCTION
10.2.2.1 Rising incidence of infectious diseases to support growth
10.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
10.3 DIAGNOSTICS
10.3.1 USE OF CULTURED CELLS IN CYTOGENETICS AND ASSAY VALIDATION TO SUPPORT SEGMENT GROWTH
10.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
10.4.1 CELL & GENE THERAPY
10.4.1.1 Rising approvals and manufacturing investments in advanced therapies to propel segment growth
10.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
10.5 DRUG SCREENING & DEVELOPMENT
10.5.1 ADOPTION OF HUMAN-RELEVANT 3D MODELS AND AUTOMATED SCREENING PLATFORMS TO PROPEL SEGMENT GROWTH
10.6 OTHER APPLICATIONS
11 CELL CULTURE MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.2.1 INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH
11.3 HOSPITALS & DIAGNOSTIC LABORATORIES
11.3.1 GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH
11.5 OTHER END USERS
12 CELL CULTURE MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Strong biologics pipeline and domestic cell therapy manufacturing investments to bolster growth
12.2.2 CANADA
12.2.2.1 Increasing funding and investments for cell-based therapies to boost market
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Biologics manufacturing strength and mRNA oncology investments to drive demand
12.3.2 UK
12.3.2.1 ATMP clinical infrastructure and government life sciences strategy to boost growth
12.3.3 FRANCE
12.3.3.1 Rising number of cell-based research projects to enhance growth
12.3.4 ITALY
12.3.4.1 Strong government support for R&D activities to spur growth
12.3.5 SPAIN
12.3.5.1 Rising biotechnology R&D investment to support cell-based research applications
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Large-scale CRDMO activity and multinational cell therapy investments to accelerate growth
12.4.2 JAPAN
12.4.2.1 Rising government initiatives and increasing investments in biotech to intensify growth
12.4.3 INDIA
12.4.3.1 Favorable government support and expansion by key cell culture players to augment growth
12.4.4 SOUTH KOREA
12.4.4.1 Growing pharmaceutical sector to drive market
12.4.5 AUSTRALIA
12.4.5.1 Regenerative medicine funding and hospital-linked CAR-T manufacturing to support growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Cell therapy partnerships and vaccine manufacturing capacity to strengthen regional leadership
12.5.2 MEXICO
12.5.2.1 Pharmaceutical manufacturing investments and clinical research capacity to support steady growth
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 GCC COUNTRIES
12.6.1.1 Saudi Arabia
12.6.1.1.1 Increasing focus on expansion to drive market
12.6.1.2 UAE
12.6.1.2.1 Increasing shift from importing to manufacturing pharmaceuticals to boost market
12.6.1.3 Rest of GCC Countries
12.6.2 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Regional footprint
13.5.5.3 Product footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 INTRODUCTION
14.2 KEY PLAYERS
14.2.1 THERMO FISHER SCIENTIFIC INC.
14.2.1.1 Business overview
14.2.1.2 Products offered
14.2.1.3 Recent developments
14.2.1.3.1 Product launches
14.2.1.3.2 Deals
14.2.1.3.3 Expansions
14.2.1.4 MnM view
14.2.1.4.1 Right to win
14.2.1.4.2 Strategic choices
14.2.1.4.3 Weaknesses and competitive threats
14.2.2 DANAHER CORPORATION
14.2.2.1 Business overview
14.2.2.2 Products offered
14.2.2.3 Recent developments
14.2.2.3.1 Product launches
14.2.2.3.2 Deals
14.2.2.3.3 Expansions
14.2.2.3.4 Other developments
14.2.2.4 MnM view
14.2.2.4.1 Right to win
14.2.2.4.2 Strategic choices
14.2.2.4.3 Weaknesses and competitive threats
14.2.3 MERCK KGAA
14.2.3.1 Business overview
14.2.3.2 Products offered
14.2.3.3 Recent developments
14.2.3.3.1 Product launches
14.2.3.3.2 Deals
14.2.3.3.3 Expansions
14.2.3.4 MnM view
14.2.3.4.1 Right to win
14.2.3.4.2 Strategic choices
14.2.3.4.3 Weaknesses and competitive threats
14.2.4 SARTORIUS AG
14.2.4.1 Business overview
14.2.4.2 Products offered
14.2.4.3 Recent developments
14.2.4.3.1 Product launches
14.2.4.3.2 Deals
14.2.4.3.3 Expansions
14.2.4.4 MnM view
14.2.4.4.1 Right to win
14.2.4.4.2 Strategic choices
14.2.4.4.3 Weaknesses and competitive threats
14.2.5 CORNING INCORPORATED
14.2.5.1 Business overview
14.2.5.2 Products offered
14.2.5.3 Recent developments
14.2.5.3.1 Deals
14.2.6 FUJIFILM HOLDINGS CORPORATION
14.2.6.1 Business overview
14.2.6.2 Products offered
14.2.6.3 Recent developments
14.2.6.3.1 Product launches
14.2.6.3.2 Deals
14.2.6.3.3 Other developments
14.2.7 BD
14.2.7.1 Business overview
14.2.7.2 Product offered
14.2.7.3 Recent developments
14.2.7.3.1 Product Launches
14.2.7.3.2 Deals
14.2.7.3.3 Other developments
14.2.8 EPPENDORF SE
14.2.8.1 Business overview
14.2.8.2 Products offered
14.2.8.3 Recent developments
14.2.8.3.1 Product launches
14.2.8.3.2 Expansions
14.2.9 LONZA
14.2.9.1 Business overview
14.2.9.2 Products offered
14.2.9.3 Recent developments
14.2.9.3.1 Product launches
14.2.9.3.2 Deals
14.2.10 GETINGE
14.2.10.1 Business overview
14.2.10.2 Products offered
14.2.10.3 Recent developments
14.2.10.3.1 Product launches
14.2.10.3.2 Deals
14.2.11 AGILENT TECHNOLOGIES, INC.
14.2.11.1 Business overview
14.2.11.2 Products offered
14.2.11.3 Recent developments
14.2.11.3.1 Product launches
14.2.11.3.2 Deals
14.2.11.3.3 Expansions
14.2.12 HIMEDIA LABORATORIES
14.2.12.1 Business overview
14.2.12.2 Products offered
14.2.13 BIO-TECHNE
14.2.13.1 Business overview
14.2.13.2 Products offered
14.2.13.3 Recent developments
14.2.13.3.1 Product launches
14.2.13.3.2 Deals
14.2.13.3.3 Expansions
14.3 OTHER PLAYERS
14.3.1 MILTENYI BIOTEC
14.3.2 STEMCELL TECHNOLOGIES
14.3.3 SOLIDA BIOTECH GMBH
14.3.4 CAISSON LABS
14.3.5 PROMOCELL GMBH
14.3.6 INVIVOGEN
14.3.7 PAN-BIOTECH
14.3.8 CELLEXUS
14.3.9 MEISSNER FILTRATION PRODUCTS, INC.
14.3.10 ADOLF K?HNER AG
14.3.11 ADVANCION CORPORATION
14.3.12 BIOSPHERIX LLC
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key secondary sources
15.1.1.2 Key data from secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Key primary participants
15.1.2.2 Breakdown of primary interviews
15.1.2.3 Key data from primary sources
15.2 MARKET SIZE ESTIMATION
15.2.1 GLOBAL CELL CULTURE MARKET ESTIMATION, 2025
15.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up)
15.2.1.2 Approach 2: Primary research
15.2.1.2.1 Key industry insights
15.2.1.3 Approach 3: MnM repository analysis
15.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025
15.3 MARKET GROWTH RATE PROJECTIONS
15.4 DATA TRIANGULATION
15.5 RESEARCH ASSUMPTIONS
15.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.3.4 UNIT CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN CELL CULTURE MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 CELL CULTURE MARKET OVERVIEW
3.2 NORTH AMERICA: CELL CULTURE MARKET, BY CONSUMABLE AND COUNTRY
3.3 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 CELL CULTURE MARKET SHARE, BY END USER
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing support and funding for cell-based research
4.2.1.2 Rising demand for serum-free and animal component-free media
4.2.1.3 Growing popularity of monoclonal antibodies and biosimilars
4.2.1.4 Increasing adoption of single-use technologies
4.2.1.5 Growth in advanced therapy medicinal products
4.2.2 RESTRAINTS
4.2.2.1 High cost of cell biology research
4.2.2.2 Limitations in producing high-density cell cultures
4.2.3 OPPORTUNITIES
4.2.3.1 Rising demand for 3D cell culture
4.2.3.2 Growth opportunities in emerging economies
4.2.3.3 Increasing focus on next-generation therapeutics
4.2.4 CHALLENGES
4.2.4.1 Disposal of plastic consumables
4.2.4.2 Ethical concerns related to cell usage
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL CELL CULTURE INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.5.2 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION
5.6 TRADE ANALYSIS
5.6.1 IMPORT SCENARIO (HS CODE 382100)
5.6.2 EXPORT SCENARIO (HS CODE 382100)
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10 IMPACT OF 2025 US TARIFFS ON CELL CULTURE MARKET
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END-USE INDUSTRIES
5.10.5.1 Pharmaceutical & biotech companies
5.10.5.2 Hospitals & diagnostic laboratories
5.10.5.3 Academic & research institutes
5.10.5.4 Contract research organizations & contract development and manufacturing organizations
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 Single-use technology
6.1.1.2 Flow cytometry
6.1.1.3 Microscopy
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 High-throughput screening
6.1.2.2 Mass spectrometry
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Microfluidics and organ-on-a-chip
6.1.3.2 3D bioprinting
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR CELL CULTURE PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON CELL CULTURE MARKET
6.5.1 BEST PRACTICES IN CELL CULTURE WORKFLOW
6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 CELL CULTURE MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 SERA, MEDIA, AND REAGENTS
9.2.1.1 Media
9.2.1.1.1 Serum-free media
9.2.1.1.1.1 CHO media
9.2.1.1.1.1.1 High-yield biologics manufacturing to sustain demand for optimized CHO serum-free media
9.2.1.1.1.2 HEK 293 media
9.2.1.1.1.2.1 Viral vector manufacturing and transient expression workflows to accelerate HEK 293 media adoption
9.2.1.1.1.3 Serum-free stem cell media
9.2.1.1.1.3.1 Regenerative medicine, iPSC models, and cell therapy translation to drive specialized stem cell media demand
9.2.1.1.1.4 Vero Cell media
9.2.1.1.1.4.1 Increasing vaccine manufacturing to support demand for serum-free Vero cell media
9.2.1.1.1.5 BHK media
9.2.1.1.1.5.1 Vaccine production and viral vector workflows to support demand for BHK serum-free media
9.2.1.1.1.6 Other serum-free media
9.2.1.1.2 Classical media & salts
9.2.1.1.2.1 Standardized basal media and salt solutions to support routine culture, assay reproducibility, and vaccine production
9.2.1.1.3 Stem cell culture media
9.2.1.1.3.1 Rising use of stem cell models and regenerative medicine workflows to drive demand for specialized culture media
9.2.1.1.4 Chemically-defined media
9.2.1.1.4.1 Increasing need for reproducible, animal component-free workflows to support biologics and advanced therapy development
9.2.1.1.5 Specialty media
9.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost market
9.2.1.1.6 Other media
9.2.1.2 Reagents
9.2.1.2.1 Growth factors
9.2.1.2.1.1 Need to regulate cell proliferation, differentiation, and migration to sustain growth
9.2.1.2.2 Supplements
9.2.1.2.2.1 Need to improve cell growth, nutrient availability, and bioproduction performance to support segment growth
9.2.1.2.3 Buffers & chemicals
9.2.1.2.3.1 Ability to maintain stable pH levels to facilitate growth
9.2.1.2.4 Cell dissociation reagents
9.2.1.2.4.1 Ability to minimize cell stress and reduce cell damage to foster growth
9.2.1.2.5 Balanced salt solutions
9.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to assist growth
9.2.1.2.6 Attachment & matrix factors
9.2.1.2.6.1 Rising adoption of 3D cell culture models to support growth
9.2.1.2.7 Antibiotics/Antimycotics
9.2.1.2.7.1 Ability to mitigate growth of contaminating bacteria, fungi, and mycoplasma to drive market
9.2.1.2.8 Cryoprotective reagents
9.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to aid growth
9.2.1.2.9 Contamination detection kits
9.2.1.2.9.1 Need for rapid identification of microbial contaminants to promote growth
9.2.1.2.10 Other reagents
9.2.1.3 Sera
9.2.1.3.1 Fetal bovine sera
9.2.1.3.1.1 Increasing role of fetal bovine sera in cell proliferation to favor growth
9.2.1.3.2 Adult bovine sera
9.2.1.3.2.1 Cost-effectiveness to contribute to growth
9.2.1.3.3 Other animal sera
9.2.2 VESSELS
9.2.2.1 Cell factory systems/cell stacks
9.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive adoption
9.2.2.2 Roller/roux bottles
9.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth
9.2.2.3 Flasks
9.2.2.3.1 Growing advancements in cell culture flasks to boost market
9.2.2.4 Multiwell plates
9.2.2.4.1 Increasing adoption of multiwell plates in high-throughput or high-content screening to aid growth
9.2.2.5 Petri dishes
9.2.2.5.1 Rising use of petri dishes as sterile containers to sustain growth
9.2.3 OTHER CONSUMABLES & ACCESSORIES
9.2.3.1 Reduced preparation time and equipment performance improvements to augment growth
9.3 EQUIPMENT
9.3.1 SUPPORTING EQUIPMENT
9.3.1.1 Filtration systems
9.3.1.1.1 Sterile filtration for contamination-controlled workflows to boost market
9.3.1.2 Cell counters
9.3.1.2.1 Growing adoption of automated cell counters to propel market
9.3.1.3 Carbon dioxide incubators
9.3.1.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market
9.3.1.4 Centrifuges
9.3.1.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges
9.3.1.5 Autoclaves
9.3.1.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves
9.3.1.6 Microscopes
9.3.1.6.1 Rising adoption of live-cell imaging in 3D culture and stem cell models to support segment growth
9.3.1.7 Biosafety cabinets
9.3.1.7.1 Rising focus on contamination control and operator safety to support segment growth
9.3.1.8 Other supporting equipment
9.3.2 BIOREACTORS
9.3.2.1 Rising biologics and advanced therapy production to accelerate adoption of scalable bioreactor systems
9.3.3 STORAGE EQUIPMENT
9.3.3.1 Refrigerators & freezers
9.3.3.1.1 Increasing need for storage solutions to propel market
9.3.3.2 Cryostorage systems
9.3.3.2.1 Benefits of long-term preservation of cell cultures to support growth
10 CELL CULTURE MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 BIOPHARMACEUTICAL PRODUCTION
10.2.1 MONOCLONAL ANTIBODY PRODUCTION
10.2.1.1 Increasing approval and launch of monoclonal antibodies to amplify growth
10.2.2 VACCINE PRODUCTION
10.2.2.1 Rising incidence of infectious diseases to support growth
10.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
10.3 DIAGNOSTICS
10.3.1 USE OF CULTURED CELLS IN CYTOGENETICS AND ASSAY VALIDATION TO SUPPORT SEGMENT GROWTH
10.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
10.4.1 CELL & GENE THERAPY
10.4.1.1 Rising approvals and manufacturing investments in advanced therapies to propel segment growth
10.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
10.5 DRUG SCREENING & DEVELOPMENT
10.5.1 ADOPTION OF HUMAN-RELEVANT 3D MODELS AND AUTOMATED SCREENING PLATFORMS TO PROPEL SEGMENT GROWTH
10.6 OTHER APPLICATIONS
11 CELL CULTURE MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.2.1 INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH
11.3 HOSPITALS & DIAGNOSTIC LABORATORIES
11.3.1 GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH
11.5 OTHER END USERS
12 CELL CULTURE MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Strong biologics pipeline and domestic cell therapy manufacturing investments to bolster growth
12.2.2 CANADA
12.2.2.1 Increasing funding and investments for cell-based therapies to boost market
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Biologics manufacturing strength and mRNA oncology investments to drive demand
12.3.2 UK
12.3.2.1 ATMP clinical infrastructure and government life sciences strategy to boost growth
12.3.3 FRANCE
12.3.3.1 Rising number of cell-based research projects to enhance growth
12.3.4 ITALY
12.3.4.1 Strong government support for R&D activities to spur growth
12.3.5 SPAIN
12.3.5.1 Rising biotechnology R&D investment to support cell-based research applications
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Large-scale CRDMO activity and multinational cell therapy investments to accelerate growth
12.4.2 JAPAN
12.4.2.1 Rising government initiatives and increasing investments in biotech to intensify growth
12.4.3 INDIA
12.4.3.1 Favorable government support and expansion by key cell culture players to augment growth
12.4.4 SOUTH KOREA
12.4.4.1 Growing pharmaceutical sector to drive market
12.4.5 AUSTRALIA
12.4.5.1 Regenerative medicine funding and hospital-linked CAR-T manufacturing to support growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Cell therapy partnerships and vaccine manufacturing capacity to strengthen regional leadership
12.5.2 MEXICO
12.5.2.1 Pharmaceutical manufacturing investments and clinical research capacity to support steady growth
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 GCC COUNTRIES
12.6.1.1 Saudi Arabia
12.6.1.1.1 Increasing focus on expansion to drive market
12.6.1.2 UAE
12.6.1.2.1 Increasing shift from importing to manufacturing pharmaceuticals to boost market
12.6.1.3 Rest of GCC Countries
12.6.2 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Regional footprint
13.5.5.3 Product footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
14 COMPANY PROFILES
14.1 INTRODUCTION
14.2 KEY PLAYERS
14.2.1 THERMO FISHER SCIENTIFIC INC.
14.2.1.1 Business overview
14.2.1.2 Products offered
14.2.1.3 Recent developments
14.2.1.3.1 Product launches
14.2.1.3.2 Deals
14.2.1.3.3 Expansions
14.2.1.4 MnM view
14.2.1.4.1 Right to win
14.2.1.4.2 Strategic choices
14.2.1.4.3 Weaknesses and competitive threats
14.2.2 DANAHER CORPORATION
14.2.2.1 Business overview
14.2.2.2 Products offered
14.2.2.3 Recent developments
14.2.2.3.1 Product launches
14.2.2.3.2 Deals
14.2.2.3.3 Expansions
14.2.2.3.4 Other developments
14.2.2.4 MnM view
14.2.2.4.1 Right to win
14.2.2.4.2 Strategic choices
14.2.2.4.3 Weaknesses and competitive threats
14.2.3 MERCK KGAA
14.2.3.1 Business overview
14.2.3.2 Products offered
14.2.3.3 Recent developments
14.2.3.3.1 Product launches
14.2.3.3.2 Deals
14.2.3.3.3 Expansions
14.2.3.4 MnM view
14.2.3.4.1 Right to win
14.2.3.4.2 Strategic choices
14.2.3.4.3 Weaknesses and competitive threats
14.2.4 SARTORIUS AG
14.2.4.1 Business overview
14.2.4.2 Products offered
14.2.4.3 Recent developments
14.2.4.3.1 Product launches
14.2.4.3.2 Deals
14.2.4.3.3 Expansions
14.2.4.4 MnM view
14.2.4.4.1 Right to win
14.2.4.4.2 Strategic choices
14.2.4.4.3 Weaknesses and competitive threats
14.2.5 CORNING INCORPORATED
14.2.5.1 Business overview
14.2.5.2 Products offered
14.2.5.3 Recent developments
14.2.5.3.1 Deals
14.2.6 FUJIFILM HOLDINGS CORPORATION
14.2.6.1 Business overview
14.2.6.2 Products offered
14.2.6.3 Recent developments
14.2.6.3.1 Product launches
14.2.6.3.2 Deals
14.2.6.3.3 Other developments
14.2.7 BD
14.2.7.1 Business overview
14.2.7.2 Product offered
14.2.7.3 Recent developments
14.2.7.3.1 Product Launches
14.2.7.3.2 Deals
14.2.7.3.3 Other developments
14.2.8 EPPENDORF SE
14.2.8.1 Business overview
14.2.8.2 Products offered
14.2.8.3 Recent developments
14.2.8.3.1 Product launches
14.2.8.3.2 Expansions
14.2.9 LONZA
14.2.9.1 Business overview
14.2.9.2 Products offered
14.2.9.3 Recent developments
14.2.9.3.1 Product launches
14.2.9.3.2 Deals
14.2.10 GETINGE
14.2.10.1 Business overview
14.2.10.2 Products offered
14.2.10.3 Recent developments
14.2.10.3.1 Product launches
14.2.10.3.2 Deals
14.2.11 AGILENT TECHNOLOGIES, INC.
14.2.11.1 Business overview
14.2.11.2 Products offered
14.2.11.3 Recent developments
14.2.11.3.1 Product launches
14.2.11.3.2 Deals
14.2.11.3.3 Expansions
14.2.12 HIMEDIA LABORATORIES
14.2.12.1 Business overview
14.2.12.2 Products offered
14.2.13 BIO-TECHNE
14.2.13.1 Business overview
14.2.13.2 Products offered
14.2.13.3 Recent developments
14.2.13.3.1 Product launches
14.2.13.3.2 Deals
14.2.13.3.3 Expansions
14.3 OTHER PLAYERS
14.3.1 MILTENYI BIOTEC
14.3.2 STEMCELL TECHNOLOGIES
14.3.3 SOLIDA BIOTECH GMBH
14.3.4 CAISSON LABS
14.3.5 PROMOCELL GMBH
14.3.6 INVIVOGEN
14.3.7 PAN-BIOTECH
14.3.8 CELLEXUS
14.3.9 MEISSNER FILTRATION PRODUCTS, INC.
14.3.10 ADOLF K?HNER AG
14.3.11 ADVANCION CORPORATION
14.3.12 BIOSPHERIX LLC
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key secondary sources
15.1.1.2 Key data from secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Key primary participants
15.1.2.2 Breakdown of primary interviews
15.1.2.3 Key data from primary sources
15.2 MARKET SIZE ESTIMATION
15.2.1 GLOBAL CELL CULTURE MARKET ESTIMATION, 2025
15.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up)
15.2.1.2 Approach 2: Primary research
15.2.1.2.1 Key industry insights
15.2.1.3 Approach 3: MnM repository analysis
15.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025
15.3 MARKET GROWTH RATE PROJECTIONS
15.4 DATA TRIANGULATION
15.5 RESEARCH ASSUMPTIONS
15.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3 NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)
TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023–2026
TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2025
TABLE 6 ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2024–2026
TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
TABLE 8 CELL CULTURE MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 9 CELL CULTURE MARKET: ROLE IN ECOSYSTEM
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION, 2023–2025 (USD)
TABLE 12 IMPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND)
TABLE 13 IMPORT DATA FOR HS CODE 382100, 2021–2025 (TONS)
TABLE 14 EXPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND)
TABLE 15 EXPORT DATA FOR HS CODE 382100, 2021–2025 (TONS)
TABLE 16 CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 17 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
TABLE 19 ADVANTAGES OF SINGLE-USE OVER STAINLESS-STEEL BIOREACTORS
TABLE 20 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
TABLE 21 CELL CULTURE MARKET: INDICATIVE LIST OF PATENTS, 2026
TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET
TABLE 23 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
TABLE 29 KEY BUYING CRITERIA, BY END USER
TABLE 30 CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 41 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 48 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (MILLION LITERS)
TABLE 56 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 57 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE,
2024–2031 (USD MILLION)
TABLE 58 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 LATIN AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 MIDDLE EAST: CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 71 GCC COUNTRIES: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION,
2024–2031 (USD MILLION)
TABLE 73 NORTH AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 EUROPE: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ASIA PACIFIC: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 LATIN AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 MIDDLE EAST: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 78 GCC COUNTRIES: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 NORTH AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 EUROPE: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 LATIN AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 MIDDLE EAST: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 92 GCC COUNTRIES: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 EUROPE: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 ASIA PACIFIC: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 LATIN AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 MIDDLE EAST: CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 99 GCC COUNTRIES: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
TABLE 108 CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 114 GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 116 CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,
BY REGION, 2024–2031 (USD MILLION)
TABLE 122 GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 124 CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 130 GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 132 CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 133 NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY ME
DIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 137 MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 138 GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 140 CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 142 EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148 CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 149 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 156 NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 161 GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 163 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 177 NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178 EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180 LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 182 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 189 GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS,
BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195 MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 EUROPE: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 ASIA PACIFIC: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 201 LATIN AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 MIDDLE EAST: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 203 GCC COUNTRIES: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 206 EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,
BY REGION, 2024–2031 (USD MILLION)
TABLE 210 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 211 CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 212 NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213 EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215 LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 216 MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 217 GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218 CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 219 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 220 EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 221 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 222 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 223 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 224 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 CELL CULTURE SERA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 227 NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 228 EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 229 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 230 LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 231 MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION,
2024–2031 (USD MILLION)
TABLE 232 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 233 CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 234 NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 235 EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 237 LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 238 MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 239 GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240 CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION,
2024–2031 (USD MILLION)
TABLE 241 NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 242 EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 244 LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 245 MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 246 GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 247 CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 248 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 249 EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 250 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 251 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 252 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 253 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 256 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 257 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 258 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 259 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 260 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 261 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 262 CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 263 NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 265 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 266 LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 267 MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 268 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 269 CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 270 NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271 EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 272 ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 273 LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 274 MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 275 GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,
BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 276 CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 277 NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 278 EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 279 ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 280 LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 281 MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 282 GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 283 CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION)
TABLE 284 NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 285 EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 286 ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 287 LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 288 MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION)
TABLE 289 GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 290 CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION)
TABLE 291 NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 292 EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 293 ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 294 LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 295 MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION)
TABLE 296 GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 297 CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 298 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 299 EUROPE: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 300 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 301 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 302 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 303 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 304 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 306 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 307 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 308 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 309 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 310 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 311 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 312 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 314 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 315 EUROPE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 316 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 317 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 318 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 319 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 320 FILTRATION SYSTEMS OFFERED BY KEY PLAYERS
TABLE 1 CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3 NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)
TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023–2026
TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2025
TABLE 6 ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2024–2026
TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
TABLE 8 CELL CULTURE MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 9 CELL CULTURE MARKET: ROLE IN ECOSYSTEM
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION, 2023–2025 (USD)
TABLE 12 IMPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND)
TABLE 13 IMPORT DATA FOR HS CODE 382100, 2021–2025 (TONS)
TABLE 14 EXPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND)
TABLE 15 EXPORT DATA FOR HS CODE 382100, 2021–2025 (TONS)
TABLE 16 CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 17 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
TABLE 19 ADVANTAGES OF SINGLE-USE OVER STAINLESS-STEEL BIOREACTORS
TABLE 20 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
TABLE 21 CELL CULTURE MARKET: INDICATIVE LIST OF PATENTS, 2026
TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET
TABLE 23 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
TABLE 29 KEY BUYING CRITERIA, BY END USER
TABLE 30 CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 41 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 48 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (MILLION LITERS)
TABLE 56 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 57 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE,
2024–2031 (USD MILLION)
TABLE 58 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 LATIN AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 MIDDLE EAST: CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 71 GCC COUNTRIES: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION,
2024–2031 (USD MILLION)
TABLE 73 NORTH AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 EUROPE: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ASIA PACIFIC: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 LATIN AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 MIDDLE EAST: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 78 GCC COUNTRIES: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 NORTH AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 EUROPE: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 LATIN AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 MIDDLE EAST: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 92 GCC COUNTRIES: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 EUROPE: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 ASIA PACIFIC: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 LATIN AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 MIDDLE EAST: CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 99 GCC COUNTRIES: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
TABLE 108 CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 114 GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 116 CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA,
BY REGION, 2024–2031 (USD MILLION)
TABLE 122 GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 124 CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 125 NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 130 GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 132 CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 133 NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY ME
DIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 137 MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 138 GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 140 CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 142 EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148 CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 149 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 156 NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 161 GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 163 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 175 GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 177 NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178 EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180 LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 182 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 189 GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 191 NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS,
BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195 MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 EUROPE: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 ASIA PACIFIC: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 201 LATIN AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 MIDDLE EAST: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 203 GCC COUNTRIES: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 205 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 206 EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS,
BY REGION, 2024–2031 (USD MILLION)
TABLE 210 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 211 CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 212 NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213 EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215 LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 216 MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 217 GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218 CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 219 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 220 EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 221 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 222 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 223 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 224 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 CELL CULTURE SERA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 227 NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 228 EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 229 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 230 LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 231 MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION,
2024–2031 (USD MILLION)
TABLE 232 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 233 CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 234 NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 235 EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 237 LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 238 MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 239 GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240 CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION,
2024–2031 (USD MILLION)
TABLE 241 NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 242 EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 244 LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 245 MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 246 GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 247 CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 248 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 249 EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 250 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 251 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 252 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION)
TABLE 253 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 256 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 257 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 258 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 259 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 260 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 261 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 262 CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 263 NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 265 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 266 LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 267 MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 268 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 269 CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 270 NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271 EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 272 ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 273 LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 274 MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 275 GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES,
BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 276 CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 277 NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 278 EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 279 ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 280 LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 281 MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION)
TABLE 282 GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 283 CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION)
TABLE 284 NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 285 EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 286 ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 287 LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 288 MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION)
TABLE 289 GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 290 CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION)
TABLE 291 NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 292 EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 293 ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 294 LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 295 MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION)
TABLE 296 GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 297 CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 298 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 299 EUROPE: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 300 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 301 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 302 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 303 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 304 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 306 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 307 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 308 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 309 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION)
TABLE 310 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 311 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 312 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 314 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 315 EUROPE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 316 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 317 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 318 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 319 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 320 FILTRATION SYSTEMS OFFERED BY KEY PLAYERS
Cell Culture is the process in which cells from microbes, plants, insects or animal are grown in an artificial environment under controlled conditions. Although the conditions under which these cells are cultured vary widely with the type of cells, a regulated chemical environment which includes pH, osmotic pressure, and temperature along with a substrate that provides nutrients, growth factors, hormones, and gases are invariably a part of all cultures.
This report segments the cell culture market into two submarkets, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The cell culture equipment market consists of five equipment segments, namely, lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. On the other hand, the cell culture media, sera, and reagents market consists of six segments, namely, serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. The report segments the cell culture market on the basis of applications and geographies. The application segment included in this report are biopharmaceutical production, tissue culture and engineering, vaccine production, drug screening and development, gene therapy, toxicity testing, cancer research, and other applications. The geographic segments included in this report are North America, Europe, APAC, and Rest of the World (RoW).
Growth in the biopharmaceuticals market is a major driver for the cell culture market. It is the most integral part of biopharmaceutical development, bio-processing, and manufacturing. As the development of vaccines is another important growth driver for this market, influenza vaccines were previously developed with the help of egg-based technology. However, due its labor-intensive approach it has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture. The cell culture market is expected to witness moderate growth in the next five years.
The market is also driven by the use of animal-derived component-free media and reagents and the growing demand for advanced biologics and biosimilars from the biopharmaceutical industry. The increasing demand for automated cell culture processes and systems will also be an impetus for growth. The market is also likely to notice a shift towards contract manufacturing and research.
The serum-free media market is expected to be the fastest growing segment. Adoption of serum-free, chemically defined, and specialty media is expected to be high being an impetus of growth for this segment. The bioreactor and culture system segments form the most attractive markets in the consumables segment, in terms of revenue as well as CAGR.
Market players are making significant investments in Asia due to a favorable scenario for stem cell research. The cell culture market is fairly consolidated with major players being Becton, Dickinson and Company (U.S.), Corning (U.S.), Eppendorf (Germany), General Electric (U.S.), Lonza (Switzerland), Merck (Germany), Promocell (Germany), Sartorius (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific (U.S.).
